All In Biotech

Drug Trial Radar · NCT03701581

4-aminopyridine Treatment for Nerve Injury

4-aminopyridine Treatment for Nerve Injury Resulting From Radical Retro-Pubic Prostatectomy

Last checked: Nov 20, 2026Latest source record: Dec 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Jun 5, 2021

Primary completion

Jul 2027

Study completion Dec 2028

Sponsor

Lead sponsor
John ElfarAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 10, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 45 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush injuries.

Conditions

  • Nerve Injury
  • Prostate Cancer

Interventions

  • 4-AminopyridineDrug

    FDA-approved tablets.

  • PlaceboOther

    Placebo will be tooled to look similar to the study drug.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Michigan Incontinence Sympton Index (M-ISI) (change over time)Time frame: Pre-operative visit, and every seven days (starting after surgery, i.e., 7 days post-op) for 6 months (up to 25 times).
  2. International Index of Erectile Function (IIEF) (change over time)Time frame: Pre-operative visit, and every seven days (starting after surgery, i.e., 7 days post-op) for 6 months (up to 25 times).
  3. Placebo vs. Active Drug QuestionnaireTime frame: through study completion, an average of 1 year

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University of Arizona

    Tucson, Arizona · Recruiting

  • University of Rochester

    Rochester, New York · Terminated

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.